Status:
RECRUITING
O2 Versus CPAP Treatment of Patients Undergoing SIPE Therapy (OCTOPUS)
Lead Sponsor:
Dalarna County Council, Sweden
Conditions:
Swimming Induced Pulmonary Edema (SIPE)
Pulmonary Edema
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In swimming induced pulmonary edema (SIPE), there is a lack of knowledge regarding optimal treatment. The present study was designed to assess the benefit of continuous positive airway pressure (CPAP)...
Detailed Description
Swimming induced pulmonary edema (SIPE) is an unusual condition affecting otherwise healthy swimmers. SIPE is characterized by acute onset of dyspnea and cough, excessive sputum and occasionally hemop...
Eligibility Criteria
Inclusion
- clinical diagnosis of swimming induced pulmonary edema (SIPE) with need of acute treatment (oxygen saturation ≤91%)
- 18 years and older
- informed consent
Exclusion
- declined consent
- suspected acute coronary syndrome
- severe asthma diagnosed together with pulmonary edema where beta-agonist-inhalation is needed prior to treatment of pulmonary edema
- hemodynamic instability or decreased consciousness
Key Trial Info
Start Date :
July 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 15 2027
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04307615
Start Date
July 2 2022
End Date
July 15 2027
Last Update
February 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center of Clinical Research Dalarna
Falun, Sweden, 79182